Dudley Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Dudley Capital Management's ABBV Position: Q3 2026 in Review
Dudley Capital Management increased its AbbVie (ABBV) stake by 0.02% in Q3 2026, buying an estimated $1.02K and bringing the position to 22,311 shares worth $5.84M. The position accounts for 2.26% of the portfolio, ranked #11.
Dudley Capital Management first reported a position in ABBV in Q4 2022 and has held it in 16 quarters since. 2,337 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Dudley Capital Management held 22,311 shares of AbbVie worth $5.84M as of Q3 2026.
- Dudley Capital Management bought 4 AbbVie shares in Q3 2026, an estimated $1.02K.
- AbbVie made up 2.26% of Dudley Capital Management's portfolio in Q3 2026, its #11 holding.
- Dudley Capital Management first reported a position in AbbVie in Q4 2022 and has held it in 16 quarters since.
- 2,337 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Dudley Capital Management's 13F filing for Q3 2026, filed 23 Oct 2026.